Clik here to view.
CATIE News – Study finds large savings from investment in community-based HIV...
Chronic illness can have a huge impact on the economies of cities, regions and countries. Researchers in the U.S. have estimated that the lifetime cost of care for HIV can range from about $250,000 to...
View ArticleClik here to view.
CATIE News – Leading Canadian researcher calls for inclusion of co-infected...
Hepatitis C virus (HCV) infects the liver. Chronic infection with HCV causes inflammation in this vital organ and slowly degrades it as healthy tissue is replaced with scar tissue. This ongoing injury...
View ArticleClik here to view.
CATIE/ACT Resource – Hep C and Sex for Gay, Bi and Queer Men
In recent years, groups of gay, bi and queer men – especially HIV-positive men but also HIV-negative men – have become Hep C positive through sex. Find out more in Hep C and Sex for Gay, Bi and Queer...
View ArticleClik here to view.
CATIE News – Study finds large savings from investment in community-based HIV...
Chronic illness can have a huge impact on the economies of cities, regions and countries. Researchers in the U.S. have estimated that the lifetime cost of care for HIV can range from about $250,000 to...
View ArticleClik here to view.
Programming Connection Spotlights CATIE’s Hepatitis C Ethnocultural...
CATIE’s Hepatitis C Ethnocultural Education, Outreach and Social Marketing Program works with immigrants and newcomers to develop accessible Hep C resources in multiple languages. Learn more about how...
View ArticleClik here to view.
CATIE News – Tesamorelin (Egrifta) comes to Canada – what you need to know
Last week, Theratechnologies Inc. began marketing a new medicine called tesamorelin (Egrifta)—licensed for the treatment of excess belly fat in some HIV-positive people. Tesamorelin causes the body to...
View ArticleClik here to view.
CATIE’s Summer 2015 Positive Side newsletter
Hot off the press: the Summer 2015 edition of The Positive Side, CATIE’s health and wellness magazine for people living with HIV. In this issue: From the Front Lines: Well, well, well… HIV...
View ArticlePHAC – At a glance: Prevention of sexually transmitted and blood borne...
The Programs and Partnerships Division is pleased to announce the release of a new resource entitled At a glance: Prevention of sexually transmitted and blood borne infections among ethnocultural...
View ArticleClik here to view.
CATIE News – Leading Canadian biomedical organization recommends early...
Since the arrival of the first anti-HIV drug in the late 1980s, the question of when to begin treatment in the course of HIV disease has ignited debate. Over the years, recommendations about the ideal...
View ArticleQuestions and Answers: Prevention of sexually transmitted and blood borne...
The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada is pleased to announce the release of a new resource entitled Questions & Answers: Prevention of...
View ArticleCATIE News – Study confirms starting HIV treatment early prevents illness and...
A large, well-designed clinical trial called START has confirmed that by initiating anti-HIV therapy early—when their CD4+ cell counts are still relatively high—HIV-positive people can significantly...
View ArticleCATIE Webinar – Understanding the experience of side effects: 50 people...
Webinar, April 12, 2017 1:00 – 2:00 p.m. ET Register here! Despite the availability of new ARVs and the simplification of treatment options, side effects continue to affect people living with HIV. Side...
View Article